IFNG and breast cancer: We also determined that the native peptide P1:STAPPVHNV was not immunogenic for normal T cells in vitro (based on the MCF-7 cell line) but was highly immunogenic for breast cancer T cells and that the lytic activity did not always correlate with the IFNγ production (Figure 3, Figure 5 and Figure 7A).